Investigation of early and advanced stages in ovarian cancer using human plasma by differential scanning calorimetry and mass spectrometry
- 22 March 2016
- journal article
- research article
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 39 (5) , 668-676
Abstract
Ovarian cancer is recognized with high mortality due to asymptomatic nature of the disease and difficulties in diagnosing early stage of the cancer. The present study evaluates the use of differential scanning calorimetry (DSC) in differentiating the severity of ovarian cancer from healthy women. 47 diseased women were subdivided into four stages with respect to clinical relevance and severity. Stages I–II were regarded as early stages and stages III–IV were regarded as advanced stages. The two average transition temperatures (T m ) increased with disease severity from 64.84 and 70.32 °C (healthy) to 68.46 and 75.24 °C (stage IV), respectively. T m were increased depending on clinical groups. In addition, the change in heat capacity was also dependent on the disease severity. To further support and investigate the nature of the proposed interactions, matrix assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) analysis is employed. The results suggest the differences in peptide expression between early and advanced stage of ovarian cancer, affected abundant proteins in plasma. The combined DSC and MS approach was supportive in identifying a unique signature of ovarian cancer stages, and demonstrates the potential of DSC as a complementary diagnostic tool in the evaluation of early stage ovarian cancer.Keywords
Funding Information
- Ministry of Health and Welfare (HI12C0050)
This publication has 25 references indexed in Scilit:
- Preliminary use of differential scanning calorimetry of cerebrospinal fluid for the diagnosis of glioblastoma multiformeJournal of Neuro-Oncology, 2011
- Differential scanning calorimetry of blood plasma for clinical diagnosis and monitoringExperimental and Molecular Pathology, 2009
- Calorimetry Outside the Box: A New Window into the Plasma ProteomeBiophysical Journal, 2008
- Calorimetric Analysis of the Plasma ProteomeSeminars in Nephrology, 2007
- Cancer Biomarkers—An Invitation to the TableScience, 2006
- Advances, Challenges, and Limitations in Serum-Proteome-Based Cancer DiagnosisJournal of Proteome Research, 2005
- Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancerProteomics, 2005
- CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical useInternational Journal of Gynecological Cancer, 2005
- Organic solvent extraction of proteins and peptides from serum as an effective sample preparation for detection and identification of biomarkers by mass spectrometryProteomics, 2004
- FIGO staging classifications and clinical practice gudelines in the management of gynecologic cancersInternational Journal of Gynecology & Obstetrics, 2000